A KSHV-targeted small molecule efficiently blocks SARS-CoV-2 infection via inhibiting expression of EGFR and Cyclin A2

A KSHV-targeted small molecule efficiently blocks SARS-CoV-2 infection via inhibiting expression of EGFR and Cyclin A2

The Coronavirus Disease 2019 (COVID-19) pandemic has led to numerous cases of co-infection with SARS-CoV-2 and other viruses, including Kaposi’s sarcoma-associated herpesvirus (KSHV), worldwide. This co-infection has increased patient mortality due to the lack of efficient bi-targeted drugs. Cambogi...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhongwei Dong, Xinyu Wang, Gaowei Hu, Qingye Huang, Yulin Zhang, Yuping Jia, Shujuan Du, Caixia Zhu, Fang Wei, Daizhou Zhang, Yuyan Wang, Qiliang Cai
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Emerging Microbes and Infections
Subjects:
Cambogin
SARS-CoV-2
KSHV
bi-targeted drug
EGFR
Cyclin A2
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2024.2440490
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items